Balance Sheet Data

Hyloris Pharmaceuticals SA (HYL.BR)

13.42 €

-0.08 (-0.59%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 0.282.690.2164.4150.541,726.8611,536.4477,070.11514,872.943,439,649.12
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.772.062.871.592.62299.321,999.6413,358.7489,244.10596,202.24
Accounts Payable (%)
Capital Expenditure -2.80-0.03-1.23-0.62-1.06-127.84-854.07-5,705.68-38,117.23-254,645.17
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.